EX-23.1 5 exhibit23112-31x23.htm EX-23.1
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S‑3 (File No. 333‑225230, 333-250083, 333-255303, 333-268737, 333-275717, and 333-277040), Form S‑4 (File No. 333‑229510), and Form S-8 (File No. 333‑233864, 333-258235, and 333-274099) of Immunic, Inc. of our report dated February 22, 2024, relating to the consolidated financial statements of Immunic, Inc., which appears in this annual report on Form 10-K for the year ended December 31, 2023.
/s/ Baker Tilly US, LLP
Minneapolis, Minnesota
February 22, 2024